REGN · Regeneron Pharmaceuticals, Inc.

$803.48 -2.49 (-0.31%) At close · Aug 14

Market Cap

$82.72B

102.95M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Daniel P. Van Plew	Executive Vice President and General Manager, Industrial Operations and Product Supply	$983,382	—	$2,699,728	$4,049,757	$965,189	$82,207	$8,780,263
Andrew J. Murphy	Executive Vice President, Co-Chief Scientific Officer	$819,672	—	$2,699,728	$4,049,757	$815,164	$92,798	$8,477,119
Joseph J. LaRosa	Executive Vice President, General Counsel and Secretary10	$916,062	$1,000,000	$1,799,334	$2,699,810	$911,024	$132,740	$7,458,970
Christopher Fenimore	Executive Vice President, Finance and Chief Financial Officer6	$725,000	—	$2,199,751	$3,299,977	$721,013	$39,623	$6,985,364

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Daniel P. Van Plew	Executive Vice President and General Manager, Industrial Operations and Product Supply	$964,100	—	$2,699,968	$4,049,729	$914,931	$26,450	$8,655,178
Andrew J. Murphy	Executive Vice President, Research Robert E. Landry (retired) Former Executive Vice President, Finance and Chief Financial Officer	$803,600	—	$2,699,968	$4,049,729	$783,510	$26,450	$8,363,257
Leonard Schleifer	M.D., Ph.D. Board co-Chair, President and Chief Executive Officer	$1,941,100	—	—	—	$3,493,980	$1,387,954	$6,823,034
George Yancopoulos	M.D., Ph.D. Board co-Chair, President and Chief Scientific Officer	$1,941,100	—	—	—	$3,493,980	$1,361,703	$6,796,783
Christopher Fenimore	Executive Vice President, Finance and Chief Financial Officer	$660,000	—	$1,999,319	$2,999,683	$594,000	$15,250	$6,268,252

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Daniel P. Van Plew	Executive Vice President and General Manager, Industrial Operations and Product Supply	$931,500	—	$2,699,284	$4,049,638	$1,053,527	$26,200	$8,760,149
Andrew J. Murphy	Executive Vice President, Research Robert E. Landry (retired) Former Executive Vice President, Finance and Chief Financial Officer	$776,250	—	$2,699,284	$4,049,638	$877,939	$26,200	$8,429,311
Leonard Schleifer	M.D., Ph.D. Board co-Chair, President and Chief Executive Officer	$1,875,415	—	—	—	$4,275,946	$2,032,977	$8,184,338
George Yancopoulos	M.D., Ph.D. Board co-Chair, President and Chief Scientific Officer	$1,875,415	—	—	—	$4,275,946	$1,608,469	$7,759,830

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Andrew J. Murphy	Executive Vice President, Research Robert E. Landry (retired) Former Executive Vice President, Finance and Chief Financial Officer	$750,000	—	$2,999,842	$4,499,737	$848,250	$24,700	$9,122,529
Daniel P. Van Plew	Executive Vice President and General Manager, Industrial Operations and Product Supply	$900,000	—	$2,759,361	$4,139,777	$1,017,900	$36,499	$8,853,537
Leonard Schleifer	M.D., Ph.D. Board co-Chair, President and Chief Executive Officer	$1,811,995	—	—	—	$4,131,349	$1,060,725	$7,004,069
George Yancopoulos	M.D., Ph.D. Board co-Chair, President and Chief Scientific Officer	$1,811,995	—	—	—	$4,131,349	$650,352	$6,593,696

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Daniel P. Van Plew	Executive Vice President and General Manager, Industrial Operations and Product Supply	$822,800	—	$2,799,882	$4,199,871	$930,587	$20,950	$8,774,090
Robert Landry	Executive Vice President, Finance and Chief Financial Officer	$822,800	—	$2,559,468	$3,839,805	$1,052,182	$24,200	$8,298,455
Andrew J. Murphy	Executive Vice President, Research	$724,500	—	$2,231,397	$3,347,323	$819,410	$24,200	$7,146,830
Joseph J. LaRosa	Executive Vice President, General Counsel and Secretary	$810,000	—	$2,151,475	$3,227,316	$916,110	$22,000	$7,126,901
Leonard Schleifer	M.D., Ph.D. Board co-Chair, President and Chief Executive Officer	$1,767,800	—	—	—	$4,030,584	$672,130	$6,470,514
George Yancopoulos	M.D., Ph.D. Board co-Chair, President and Chief Scientific Officer Robert E. Landry (retired)	$1,767,800	—	—	—	$4,030,584	$599,980	$6,398,364

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Leonard Schleifer	M.D., Ph.D. President and Chief Executive Officer	$1,480,119	—	$130,000,032	—	$3,567,714	$302,256	$135,350,121
George Yancopoulos	M.D., Ph.D. President and Chief Scientific Officer	$1,258,096	—	$130,000,032	—	$3,004,391	$120,800	$134,383,319
Andrew J. Murphy	Executive Vice President, Research	$726,923	—	$5,025,288	$4,335,258	$887,250	$24,195	$10,998,914
Daniel P. Van Plew	Executive Vice President and General Manager, Industrial Operations and Product Supply	$825,577	—	$3,409,560	$3,459,499	$938,872	$20,945	$8,654,453
Robert Landry	Executive Vice President, Finance and Chief Financial Officer	$825,577	—	$949,560	$3,459,499	$938,872	$24,195	$6,197,703

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Leonard Schleifer	M.D., Ph.D. President and Chief Executive Officer	$1,377,100	—	$4,983,226	$11,699,586	$3,057,162	$338,043	$21,455,117
George Yancopoulos	M.D., Ph.D. President and Chief Scientific Officer	$1,170,500	—	$4,983,226	$11,699,586	$2,598,510	$212,313	$20,664,135
Andrew J. Murphy	Executive Vice President, Research	$600,000	—	$4,702,308	$3,526,669	$666,900	$23,470	$9,519,347
Robert Landry	Executive Vice President, Finance and Chief Financial Officer	$730,000	—	$2,840,008	$3,526,669	$811,395	$23,470	$7,931,542
Daniel P. Van Plew	Executive Vice President and General Manager, Industrial Operations and Product Supply	$683,100	—	$2,840,008	$3,526,669	$759,266	$20,470	$7,829,513

Fiscal 2018

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Leonard Schleifer	M.D., Ph.D. President and Chief Executive Officer	$1,330,500	—	—	$21,339,913	$2,953,710	$896,432	$26,520,555
George Yancopoulos	M.D., Ph.D. President and Chief Scientific Officer Robert E. Landry Executive Vice President, Finance and Chief Financial Officer	$1,130,900	—	—	$21,339,913	$2,510,598	$399,718	$25,381,129
Robert Landry	Executive Vice President, Finance and Chief Financial Officer	$680,000	—	$4,767,500	$3,308,184	$581,400	$19,535	$9,356,619
Daniel P. Van Plew	Executive Vice President and General Manager, Industrial Operations and Product Supply	$660,000	—	—	$7,650,147	$677,160	$19,915	$9,007,222

Fiscal 2017

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Leonard Schleifer	M.D., Ph.D. President and Chief Executive Officer	$1,285,500	—	—	$21,967,210	$2,468,160	$787,188	$26,508,058
George Yancopoulos	M.D., Ph.D. President and Chief Scientific Officer	$1,092,700	—	—	$21,967,210	$2,097,984	$141,345	$25,299,239
Daniel P. Van Plew	Executive Vice President and General Manager, Industrial Operations and Product Supply	$560,000	—	—	$7,875,030	$524,160	$19,410	$8,978,600
Robert Landry	Executive Vice President, Finance and Chief Financial Officer	$618,000	—	—	$3,675,566	$482,040	$19,130	$4,794,736

Executive changes

Person	Role	Change	Effective	Filed
David P. Schenkein, M.D.	Class II director	Appointed	2023-09-08	2023-09-08
Kathryn Guarini, Ph.D.	Class III director	Appointed	2023-09-08	2023-09-08
Marc Tessier-Lavigne, Ph.D.	director	Retired	2023-09-01	2023-09-08
Craig B. Thompson, M.D.	director	Appointed	2022-10-03	2022-10-03

Key facts CIK 872589 CUSIP 75886F107 13F (30d) 1194 filings 1154 filers Visit website Investor relations